Stockholm - Delayed Quote SEK
Acarix AB (publ) (ACARIX.ST)
At close: October 25 at 5:29 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-73,220.0000
-81,366.0000
-74,869.0000
-48,007.0000
-36,686.0000
--
Investing Cash Flow
-136.0000
--
-151.0000
-43.0000
--
--
Financing Cash Flow
96,708.0000
106,229.0000
69,030.0000
-164.0000
47,350.0000
--
End Cash Position
49,651.0000
35,149.0000
11,161.0000
15,860.0000
64,113.0000
--
Capital Expenditure
--
--
-151.0000
-43.0000
--
--
Issuance of Capital Stock
96,767.0000
106,443.0000
69,335.0000
580.0000
48,152.0000
--
Free Cash Flow
-73,356.0000
-81,366.0000
-75,020.0000
-48,050.0000
-36,686.0000
--
12/31/2019 - 12/19/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NEOLA.ST Neola Medical AB (publ)
2.4400
-7.58%
6YC.F Senzime AB (publ)
0.5030
+1.11%
SDET.ST SensoDetect Aktiebolag (publ)
0.2240
-8.57%
SCIB.ST SciBase Holding AB (publ)
0.5100
+2.00%
QLIFE.ST Qlife Holding AB (publ)
2.4200
0.00%
QLINEA.ST Q-linea AB (publ)
2.4250
0.00%
XVIVO.ST Xvivo Perfusion AB (publ)
478.50
+0.74%
EMBLA.CO Embla Medical hf
35.00
-0.57%
GETI-B.ST Getinge AB (publ)
198.50
-1.19%
VITR.ST Vitrolife AB (publ)
235.20
-2.65%